Eli Lilly & Co.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
LLY Company Description
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
LLY Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view LLY Smart Score
Score Breakdown
LLY Company Description
Show More
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. Show Less
$LLY stock is featured in our Josh Gottheimer, Sheldon Whitehouse, and Wall Street Conviction strategies.
See All StrategiesAll
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of LLY by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by LLY's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on LLY's company Twitter account
WallStreetBets
Number of mentions of LLY in WallStreetBets Daily Discussion
LLY News
Recent insights relating to LLY
CNBC Recommendations
Recent picks made for LLY stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in LLY
Corporate Flights
Flights by private jets registered to LLY
Our Analysis